wwPDB validation report of PDB entry 2Z3D

UNP residues 3241-3546, SARS-CoV 3C-like peptidase

Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) 3C-like Peptidase

THE INHIBITOR (CHAIN I) IS A MIXTURE OF A THIOACYL AND EPISULFIDE FORMS. THE UNBOUND FORM OF THE INHIBITOR CONTAINS A PHTHALHYDRAZIDE GROUP THAT IS LEAVING UPON INHIBITOR BINDING.

HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS

Replicase polyprotein 1ab (pp1ab) (E.C.3.4.22.-)
A Mechanistic view of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-Like peptidase

The largest off-origin peak in the Patterson function is 5.75% of the height of the origin peak. No significant pseudotranslation is detected.

structure factor analysis and validation

geometric validation package for ligand chemistry in protein x-ray structures

20191225.v01 (using entries in the PDB archive December 25th 2019)